Recent years have shown an increased interest in the cognitive and neural basis of emotion in psychiatric and neurological disorders. Indeed, various methods of behavioural and neural measurement of emotional processes are continually being developed and refined, which has led to an explosion of research in this area. This Special Issue of Cognitive Neuropsychiatry brings together timely reviews and new empirical papers regarding the cognitive and neural basis of emotional processing in health and disease, written by renowned researchers in the field. Clinical conditions that are addressed include amygdala damage, bipolar disorder, schizophrenia, social phobia, psychopathy and alexithymia.

Recent years have shown an increased interest in the cognitive and neural basis of emotion in psychiatric and neurological disorders. Indeed, various methods of behavioural and neural measurement of emotional processes are continually being developed and refined, which has led to an explosion of research in this area. This Special Issue of Cognitive Neuropsychiatry brings together timely reviews and new empirical papers regarding the cognitive and neural basis of emotional processing in health and disease, written by renowned researchers in the field. Clinical conditions that are addressed include amygdala damage, bipolar disorder, schizophrenia, social phobia, psychopathy and alexithymia.

Apathy is characterized by loss of motivation, decreased initiative, and emotional blunting. It is highly prevalent in neurological, and psychiatric disorders like Alzheimer's disease, traumatic brain injury, schizophrenia, Parkinson's disease, Huntington's disease, cerebrovascular disorders, and mild behavioural impairment. It has negative outcomes including impairments in activities of daily living, caregiver burden, and higher rates of institutionalization and mortality. The definition of apathy has changed over the years alongside the development of diagnostic criteria and apathy scales and measurements. Apathy is emerging as a treatment target with interest in pharmacological, non-pharmacological, and neuromodulatory treatments for apathy. There is also an increased understanding of the neurobiology of apathy with functional and structural neuroimaging research studies. This book is a comprehensive, in-depth review from experts in neurology and psychiatry. It reviews the current state of apathy in these various disorders while also summarizing apathy diagnostic criteria, scales and measurements, neuropathology, and treatments.

Hallucinations are a troublesome and distressing symptom for countless patients who suffer from psychiatric or neurological conditions. In recent years, a number of new treatment strategies have been developed to help patients suffering from these symptoms.
This book brings together the work of leading experts in this area, to provide a practical guide to the assessment, evaluation, and treatment of hallucinations. It includes a range of interventions, including: Pharmacological, Transcranial Magnetic Stimulation, Cognitive Behavioural Therapy, Hallucinations focused Integrative Therapy (HIT), normalizing techniques, coping strategies, self-help approaches, Acceptance and Commitment Therapy, Attention Training Technique, Competitive Memory Training, appraisal-based cognitive therapy, and cognitive therapy for command hallucinations. As well as providing practical advice, the chapters also contain overviews of the respective areas of research, including references to the evidence base for each intervention - highlighting those interventions in need of more empirical support. Each chapter describes how to evaluate and treat the patient, often using clinical vignettes or case studies to illustrate the treatment process.
The book will be a valuable guide for psychiatrists, clinical psychologists, and counsellors, increasingly required to help patients suffering from these distressing symptoms.